JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 14 No. 8 558-564
© 1973 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fish, M. B.
Right arrow Articles by Pollycove, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fish, M. B.
Right arrow Articles by Pollycove, M.

Cranial Scintiphotographic Blood Flow Defects in Arteriographically Proven Cerebral Vascular Disease

Mathews B. Fish, Barbara Barnes and Myron Pollycove

University of California School of Medicine and San Francisco General Hospital, San Francisco, California

Correspondence: For reprints contact: Mathews B. Fish, Clinical Laboratories, Bldg. 100, Room 163, San Francisco General Hospital, 1001 Potrero St., San Francisco, Calif. 94110.

ABSTRACT

The accuracy and sensitivity of rapid sequential cranial scintiphotography after intravenous bolus injection of 99mTc in CVD were assessed by correlation with the vascular changes and clinical phases of 84 angiographically proven cases of CYD. Patients were divided into three clinical groups: (A) asymptomatic and transient ischemic attacks; (B) acute and subacute strokes; (C) chronic completed strokes. Abnormality of the scintiphotographic study was noted in 53% of Group 1, 83% of Group 2, and 75% of Group 3. Of those with isotopic abnormalities, all except one patient had a HF abnormality. Most patients in Group 1 were with out BBB defects, and only half of the patients in Group 2 and one-third of the patients in Group 3 with HF abnormalities had BBB defects. Correlation of HF studies with specific arteriographic findings revealed isotopic abnormalities in 68% of the patients with extracranial vascular disease and 85% of patients with intracranial vascular disease. While less frequent, BBB defects occurred in 25% of the patients with extracranial involvement and in 44% of patients with intracranial involvement. These studies also indicate that the frequency of BF abnormalities correlated with the severity of vascular involvement and the degree of symptomatology.

The overall diagnostic accuracy in this study of 75% is noteworthy because over one-half of the patients were not in the acute or subacute phase of their disease. Use of conventional BBB studies alone would reduce overall diagnostic accuracy from 75 to 32%.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1973 by the Society of Nuclear Medicine.